These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28695622)

  • 1. Sleep disturbance by pramipexole is modified by Meis1 in mice.
    Salminen AV; Schormair B; Flachskamm C; Torres M; Müller-Myhsok B; Kimura M; Winkelmann J
    J Sleep Res; 2018 Aug; 27(4):e12557. PubMed ID: 28695622
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Salminen AV; Garrett L; Schormair B; Rozman J; Giesert F; Niedermeier KM; Becker L; Rathkolb B; Rácz I; ; Klingenspor M; Klopstock T; Wolf E; Zimmer A; Gailus-Durner V; Torres M; Fuchs H; Hrabě de Angelis M; Wurst W; Hölter SM; Winkelmann J
    Dis Model Mech; 2017 Aug; 10(8):981-991. PubMed ID: 28645892
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice.
    Salminen AV; Lam DD; Winkelmann J
    Adv Pharmacol; 2019; 84():175-184. PubMed ID: 31229170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of dopaminergic signalling in Meis homeobox 1 (Meis1) deficient mice as an animal model of restless legs syndrome.
    Cathiard L; Fraulob V; Lam DD; Torres M; Winkelmann J; Krężel W
    J Sleep Res; 2021 Oct; 30(5):e13311. PubMed ID: 34008292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessing GWAS findings for the shared genetic basis of insomnia and restless legs syndrome.
    El Gewely M; Welman M; Xiong L; Yin S; Catoire H; Rouleau G; Montplaisir JY; Desautels A; Warby SC
    Sleep; 2018 Nov; 41(11):. PubMed ID: 30215811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patient-enriched MEIS1 coding variant causes a restless legs syndrome-like phenotype in mice.
    Leu CL; Lam DD; Salminen AV; Wefers B; Becker L; Garrett L; Rozman J; Wurst W; Hrabě de Angelis M; Hölter SM; Winkelmann J; Williams RH
    Sleep; 2024 May; 47(5):. PubMed ID: 38314840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Meis1, a transcriptional regulator, in mice and worms: Neurochemical and behavioral characterizations with implications in the restless legs syndrome.
    Lyu S; Xing H; Liu Y; Girdhar P; Zhang K; Yokoi F; Xiao R; Li Y
    J Neurochem; 2020 Dec; 155(5):522-537. PubMed ID: 32910473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEIS1 variant as a determinant of autonomic imbalance in Restless Legs Syndrome.
    Thireau J; Farah C; Molinari N; Bouilloux F; Torreilles L; Winkelmann J; Scholz S; Richard S; Dauvilliers Y; Marmigère F
    Sci Rep; 2017 Apr; 7():46620. PubMed ID: 28425489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restless in the mouse cage-A new genetic model for restless legs syndrome: An Editorial Highlight for "Deficiency of Meis1, a transcriptional regulator, in mice and worms:Neurochemical and behavioral characterizations with implications in the restless legs syndrome" on page 522.
    Stegmüller J
    J Neurochem; 2020 Dec; 155(5):471-474. PubMed ID: 33011998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct interaction between two Restless Legs Syndrome predisposing genes: MEIS1 and SKOR1.
    Catoire H; Sarayloo F; Mourabit Amari K; Apuzzo S; Grant A; Rochefort D; Xiong L; Montplaisir J; Earley CJ; Turecki G; Dion PA; Rouleau GA
    Sci Rep; 2018 Aug; 8(1):12173. PubMed ID: 30111810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptible genes of restless legs syndrome in migraine.
    Fuh JL; Chung MY; Yao SC; Chen PK; Liao YC; Hsu CL; Wang PJ; Wang YF; Chen SP; Fann CS; Kao LS; Wang SJ
    Cephalalgia; 2016 Oct; 36(11):1028-1037. PubMed ID: 26643377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineral absorption is an enriched pathway in a brain region of restless legs syndrome patients with reduced MEIS1 expression.
    Sarayloo F; Dionne-Laporte A; Catoire H; Rochefort D; Houle G; Ross JP; Akçimen F; Barros Oliveira R; Turecki G; Dion PA; Rouleau GA
    PLoS One; 2019; 14(11):e0225186. PubMed ID: 31725784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis.
    Catoire H; Dion PA; Xiong L; Amari M; Gaudet R; Girard SL; Noreau A; Gaspar C; Turecki G; Montplaisir JY; Parker JA; Rouleau GA
    Ann Neurol; 2011 Jul; 70(1):170-5. PubMed ID: 21710629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted resequencing and systematic in vivo functional testing identifies rare variants in MEIS1 as significant contributors to restless legs syndrome.
    Schulte EC; Kousi M; Tan PL; Tilch E; Knauf F; Lichtner P; Trenkwalder C; Högl B; Frauscher B; Berger K; Fietze I; Hornyak M; Oertel WH; Bachmann CG; Zimprich A; Peters A; Gieger C; Meitinger T; Müller-Myhsok B; Katsanis N; Winkelmann J
    Am J Hum Genet; 2014 Jul; 95(1):85-95. PubMed ID: 24995868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels.
    Xiong L; Catoire H; Dion P; Gaspar C; Lafrenière RG; Girard SL; Levchenko A; Rivière JB; Fiori L; St-Onge J; Bachand I; Thibodeau P; Allen R; Earley C; Turecki G; Montplaisir J; Rouleau GA
    Hum Mol Genet; 2009 Mar; 18(6):1065-74. PubMed ID: 19126776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model of MEIS1-associated restless legs syndrome: insights and challenges.
    Mogavero MP; Ferri R; Ferini-Strambi L
    Sleep; 2024 May; 47(5):. PubMed ID: 38150482
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intronic elements associated with insomnia and restless legs syndrome exhibit cell-type-specific epigenetic features contributing to MEIS1 regulation.
    Lam DD; Antic Nikolic A; Zhao C; Mirza-Schreiber N; Krężel W; Oexle K; Winkelmann J
    Hum Mol Genet; 2022 Jun; 31(11):1733-1746. PubMed ID: 34888668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep.
    Manconi M; Ferri R; Zucconi M; Clemens S; Rundo F; Oldani A; Ferini-Strambi L
    Sleep Med; 2011 Jan; 12(1):47-55. PubMed ID: 20851046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.